Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
The risk of oesophageal and ga...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
The risk of oesophageal and gastric cancer incidence and mortality in alendronate users: National cohort study
Bibliographic Details
Main Authors:
Abrahamsen, B
,
Pazianas, M
,
Eiken, P
,
Russell, R
,
Eastell, R
Format:
Conference item
Published:
2011
Holdings
Description
Similar Items
Staff View
Similar Items
Esophageal and gastric cancer incidence and mortality in alendronate users.
by: Abrahamsen, B, et al.
Published: (2012)
Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.
by: Pazianas, M, et al.
Published: (2012)
Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users.
by: Eiken, P, et al.
Published: (2017)
Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study
by: Prieto Alhambra, D, et al.
Published: (2016)
Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment
by: Abrahamsen, B, et al.
Published: (2016)